Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Malaysian Journal of Medicine and Health Sciences ; : 55-62, 2021.
Article Dans Anglais | WPRIM | ID: wpr-979124

Résumé

@#Introduction: Cervical cancer is responsible for women’s morbidity and mortality throughout the world. In developing countries women usually present in advanced stage, awareness of cervical cancer can enhance women inclination towards regular cervical screening which can detect early pre-invasive lesions. The aim of the study was to assess the awareness of cervical cancer among King Faisal University community visiting gynecology clinic, Al Ahsa Saudi Arabia. Methods: A questionnaire oriented cross-sectional study was conducted and 385 females were enrolled by systematic random sampling. The questionnaire contained 14 questions about cervical cancer and six barrier statements for cervical screening. SPSS software version 26.0 was used for data entry and analysis. Results: Total 385 females participated in the study. Majority 73.2% (n=282) had heard about cervical cancer and found significant association with age 36-45yr (p=0.001), married with two children (p=0.003), employed (p=0.001), Master level education (p=0.001) and with Saudi nationality (p=0.028). Logistic regression revealed age increases likely hood of adequate knowledge almost by one fold (odds ratio 0.954, 95% CI: 0.925-0.984) and having Saudi nationality increases it by two folds (odds ratio 2.056, 95%CI: 1.228-3.440). Almost 80% were aware of screening test, 18.4% had undergone one time an opportunistic screening test. Significant proportion of Saudi nationals had heard of HPV vaccines (p= 0.04). Conclusion: Participants had adequate knowledge of cervical cancer but had low screening test practice. There is need to implement regular cervical screening practice at national level.

2.
PJMR-Pakistan Journal of Medical Research. 2008; 47 (2): 48-49
Dans Anglais | IMEMR | ID: emr-89824

Résumé

The disease spectrum in gestational trophoblastic disease [GTD] varies from benign to malignant. In most cases it can be treated successfully but sometimes even a hydatidiform mole can be fatal if it remains unattended. It is an important condition that can be diagnosed and cured with chemotherapy. The gestational trophoblastic disease [GTD is a proliferative anddegenerative disorder of placental elements and includes complete and partial mole [90%] invasive mole [5-8%] choriocarcinoma [1-2%] and placental site tumour [1-2%].[1] World Health Organization classification divides GTD into the premalignant disorders which include partial and complete hydatidiform moles and the malignant disorders of invasive mole which, include choriocarcinoma and placental site tumours. Incidence is higher in Africa and Asia with geographical and racial variations.[2] The reported incidence of molar pregnancies in Europe and North America is 0.2-1.5per 1000 live births


Sujets)
Humains , Femelle , Tumeurs de l'utérus , Grossesse , Abdomen aigu , Maladie trophoblastique gestationnelle , Môle invasive/imagerie diagnostique , Môle invasive/thérapie , Organisation mondiale de la santé , Sous-unité bêta de la gonadotrophine chorionique humaine , Choriocarcinome
SÉLECTION CITATIONS
Détails de la recherche